Transduction of Human CD34+CD38- Bone Marrow and Cord Blood-Derived SCID-Repopulating Cells with Third-Generation Lentiviral Vectors
Authors:
- Guillermo GuenecheaGGGuillermo Guenechea
- Daniel S. PereiraDPDaniel S. Pereira
- Michael KellyMKMichael Kelly
- Luigi NaldiniLNLuigi Naldini
- John E. DickJDJohn E. Dick
Open Access
- 1 June 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (6) , 566-573
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient MiceBlood, 1998
- High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free ConditionsBlood, 1998
- Retrovirus-Mediated Gene Transfer into Human CD34 + 38 low Primitive Cells Capable of Reconstituting Long-Term Cultures In Vitro and Nonobese Diabetic–Severe Combined Immunodeficiency Mice In VivoHuman Gene Therapy, 1998
- Efficient Retroviral-Mediated Gene Transfer to Human Cord Blood Stem Cells With In Vivo Repopulating PotentialBlood, 1998
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapyNature Medicine, 1996
- Normal and leukemic human stem cells assayed in SCID miceSeminars in Immunology, 1996
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiencyNature Medicine, 1995
- Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocolsHuman Molecular Genetics, 1995